The Current Ratio as of December 2024 (TTM) for PaxMedica, Inc. Common Stock (PXMD) is 0.38

According to PaxMedica, Inc. Common Stock’s latest financial reports and current stock price. The company's current Current Ratio is 0.38. This represents a change of -78.12% compared to the average of 1.73 of the last 4 quarters.

PaxMedica, Inc. Common Stock (PXMD) Historical Current Ratio (quarterly & annually)

How has PXMD Current Ratio performed in the past?

The mean historical Current Ratio of PaxMedica, Inc. Common Stock over the last ten years is 1.01. The current 0.38 Current Ratio has changed 3.65% with respect to the historical average. Over the past ten years (40 quarters), PXMD's Current Ratio was at its highest in in the December 2023 quarter at 3.16. The Current Ratio was at its lowest in in the March 2019 quarter at 0.

PaxMedica, Inc. Common Stock (PXMD) Current Ratio by Quarter and Year

Discovering the peaks and valleys of PaxMedica, Inc. Common Stock Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

PaxMedica, Inc. Common Stock (PXMD) Average Current Ratio

How has PXMD Current Ratio performed in the past?

The current Current Ratio of PaxMedica, Inc. Common Stock (PXMD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

PaxMedica, Inc. Common Stock (PXMD) Current Ratio vs. Peers

How is PXMD’s Current Ratio compared to its peers?

PaxMedica, Inc. Common Stock’s Current Ratio is less than Quoin Pharmaceuticals, Ltd. (3.02), greater than Blue Water Vaccines, Inc. (0.06), less than Revelation Biosciences, Inc. (1.64), less than Hillstream BioPharma, Inc. (2.25), less than Unicycive Therapeutics, Inc. (3.61), less than Cardio Diagnostics Holdings, Inc. (8.51), less than Virax Biolabs Group Limited (25.94), less than Allarity Therapeutics, Inc. (2.75), greater than Kiromic BioPharma, Inc. (0.22), less than Biodexa Pharmaceuticals Plc (2.16), less than Kiora Pharmaceuticals, Inc. (8.97), less than ZyVersa Therapeutics, Inc. (33.83), less than Palisade Bio, Inc. (3.31), less than Apexigen, Inc. (1.29), less than Immix Biopharma, Inc. (3.47),

Build a custom stock screener for PaxMedica, Inc. Common Stock (PXMD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PaxMedica, Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

PaxMedica, Inc. Common Stock (PXMD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like PaxMedica, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.